Cargando…
The return of chloroquine-susceptible Plasmodium falciparum malaria in Zambia
BACKGROUND: Plasmodium falciparum resistance to anti-malarial drugs remains a major obstacle to malaria control and elimination. The parasite has developed resistance to every anti-malarial drug introduced for wide-scale treatment. However, the spread of resistance may be reversible. Malawi was the...
Autores principales: | Mwanza, Sydney, Joshi, Sudhaunshu, Nambozi, Michael, Chileshe, Justin, Malunga, Phidelis, Kabuya, Jean-Bertin Bukasa, Hachizovu, Sebastian, Manyando, Christine, Mulenga, Modest, Laufer, Miriam |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5139104/ https://www.ncbi.nlm.nih.gov/pubmed/27919256 http://dx.doi.org/10.1186/s12936-016-1637-3 |
Ejemplares similares
-
Artemisinin-based combination therapy in pregnant women in Zambia: efficacy, safety and risk of recurrent malaria
por: Nambozi, Michael, et al.
Publicado: (2017) -
Defining the malaria burden in Nchelenge District, northern Zambia using the World Health Organization malaria indicators survey
por: Nambozi, Michael, et al.
Publicado: (2014) -
Safety and efficacy of dihydroartemisinin-piperaquine versus artemether-lumefantrine in the treatment of uncomplicated Plasmodium falciparum malaria in Zambian children
por: Nambozi, Michael, et al.
Publicado: (2011) -
Efficacy and safety of artemether–lumefantrine as treatment for Plasmodium falciparum uncomplicated malaria in adult patients on efavirenz-based antiretroviral therapy in Zambia: an open label non-randomized interventional trial
por: Banda, Clifford G., et al.
Publicado: (2019) -
Return of chloroquine-sensitive Plasmodium falciparum parasites and emergence of chloroquine-resistant Plasmodium vivax in Ethiopia
por: Mekonnen, Seleshi Kebede, et al.
Publicado: (2014)